Provided by Tiger Trade Technology Pte. Ltd.

BioLife Solutions

35.80
-1.2700-3.43%
Volume:374.11K
Turnover:13.47M
Market Cap:1.75B
PE:30.78
High:37.25
Open:36.98
Low:35.79
Close:37.07
52wk High:38.10
52wk Low:17.86
Shares:48.90M
Float Shares:42.68M
Volume Ratio:0.78
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.16
EPS(LYR):-0.0962
ROE:12.83%
ROA:0.26%
PB:4.17
PE(LYR):-372.06

Loading ...

Press Release: BioLife Solutions Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

BioLife Solutions (BLFS) Receives a Buy from Craig-Hallum

TIPRANKS
·
Apr 24

BioLife Solutions to report Q1 results, host conference call

Reuters
·
Apr 24

Merit Medical publishes 2025 annual report, cites record revenue growth

Reuters
·
Apr 04

BioLife Solutions management to meet virtually with Northland

TIPRANKS
·
Apr 02

BioLife’s Chief Quality and Operations Karen Foster sells $49,000 BLFS shares

Reuters
·
Apr 01

BioLife Solutions pullback creates buying opportunity, says Northland

TIPRANKS
·
Mar 24

BioLife Solutions Earnings Call Signals Profitable Growth

TIPRANKS
·
Mar 09

Maxim Group Sticks to Their Buy Rating for BioLife Solutions (BLFS)

TIPRANKS
·
Mar 05

BioLife Solutions Highlights Growth and Strategic Refocus in Presentation

TIPRANKS
·
Mar 03

BioLife Solutions Up Over 11%, on Pace for Largest Percent Increase Since November 2024 -- Data Talk

Dow Jones
·
Feb 28

Northland Securities Sticks to Its Buy Rating for BioLife Solutions (BLFS)

TIPRANKS
·
Feb 28

Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and BioLife Solutions (BLFS)

TIPRANKS
·
Feb 27

Stock Track | BioLife Solutions Soars 6.51% After-Hours on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track
·
Feb 27

BioLife Solutions Q4 revenue rises 20% yr/yr

Reuters
·
Feb 27

BioLife Solns Q4 Adj. EPS $0.04 Beats $(0.02) Estimate, Sales $24.764M Beat $24.082M Estimate.

Benzinga Earnings
·
Feb 27

BioLife Solutions Q4 Adjusted Gross Margin 64%

THOMSON REUTERS
·
Feb 27

Press Release: BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

Dow Jones
·
Feb 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST)

TIPRANKS
·
Feb 27